60.26
price up icon2.99%   1.75
after-market Handel nachbörslich: 61.00 0.74 +1.23%
loading

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
25.13%
226.22
180.79 162.17 139.92 152.98
Operating Income/Loss
25.13%
-226.22
-180.79 -162.17 -139.92 -152.98
Nonoperating Income/Loss
48.84%
59.65
40.08 - - -
Income/Loss From Continuing Operations Before Tax
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Net Income/Loss
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.25%
136.03
135.69 4.4009 123.69 117.26
Diluted Average Shares
0.25%
136.03
135.69 4.4009 123.69 117.26
Basic Earnings Per Share
17.31%
-1.22
-1.04 -1.02 -0.83 -1.10
Diluted Earnings Per Share
17.31%
-1.22
-1.04 -1.02 -0.83 -1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$27.76
price up icon 2.25%
$103.69
price up icon 1.83%
$100.84
price down icon 0.47%
$109.93
price down icon 0.20%
$159.03
price down icon 3.57%
biotechnology ONC
$370.64
price up icon 2.35%
Kapitalisierung:     |  Volumen (24h):